Purification of breast cancer resistance protein ABCG2 and role of arginine-482

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cellular and Molecular Life Sciences (CMLS)

• Publication date

  2006-07-17

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00018-006-6159-7PMID 16847575PMCID PMC11136364
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP/ABCG2)

  2006cited by this paper
• The role of the human ABCG2 multidrug transporter and its variants in cancer therapy and toxicology.

  2006cited by this paper
• The structures of MsbA: Insight into ABC transporter‐mediated multidrug efflux

  2006cited by this paper
• Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition.

  2005cited by this paper
• Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2.

  2005cited by this paper
• Arginine-482 is not essential for transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2).

  2005cited by this paper
• ABCG2 harboring the Gly482 mutation confers high-level resistance to various hydrophilic antifolates.

  2005cited by this paper
• Reversal of breast cancer resistance protein (BCRP/ABCG2) -mediated drug resistance by novobiocin, a coumermycin antibiotic

  2004cited by this paper
• ABCG2 – a transporter for all seasons

  2004cited by this paper
• Arginine482 to threonine mutation in the breast cancer resistance protein ABCG2 inhibits rhodamine 123 transport while increasing binding.

  2004cited by this paper
• High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter.

  2004cited by this paper
• Pheophorbide a Is a Specific Probe for ABCG2 Function and Inhibition

  2004cited by this paper
• Reversal of breast cancer resistance protein (BCRP/ABCG2)‐mediated drug resistance by novobiocin, a coumermycin antibiotic

  2004cited by this paper
• Multiple flavonoid-binding sites within multidrug resistance protein MRP1

  2003cited by this paper
• Functional Characterization of Human Breast Cancer Resistance Protein ( BCRP , ABCG 2 ) Expressed in the Oocytes of Xenopus laevis

  2003cited by this paper
• Many P-glycoprotein substrates do not inhibit the transport process across cell membranes

  2003cited by this paper
• Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

  2003cited by this paper
• Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.

  2003cited by this paper
• Functional characterization of human breast cancer resistance protein (BCRP, ABCG2) expressed in the oocytes of Xenopus laevis.

  2003cited by this paper
• Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport.

  2003cited by this paper
• Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants

  2003cited by this paper
• Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.

  2002cited by this paper
• Characterization of Drug Transport, ATP Hydrolysis, and Nucleotide Trapping by the Human ABCG2 Multidrug Transporter

  2002cited by this paper
• A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for Doxorubicin resistance.

  2002cited by this paper
• Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance.

  2002cited by this paper
• The Role of Half-Transporters in Multidrug Resistance

  2001cited by this paper
• Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site.

  2001cited by this paper
• Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells.

  2001cited by this paper
• Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells.

  2001cited by this paper
• Allosteric Interactions between the Two Non-equivalent Nucleotide Binding Domains of Multidrug Resistance Protein MRP1*

  2000cited by this paper
• Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein.

  2000cited by this paper
• Prenyl-flavonoids as potent inhibitors of the Pdr5p multidrug ABC transporter from Saccharomyces cerevisiae.

  2000cited by this paper
• Intrinsic fluorescence of the P-glycoprotein multidrug transporter: sensitivity of tryptophan residues to binding of drugs and nucleotides.

  2000cited by this paper
• Communication between multiple drug binding sites on P-glycoprotein.

  2000cited by this paper
• Correlation between the affinity of flavonoids binding to the cytosolic site of Leishmania tropica multidrug transporter and their efficiency to revert parasite resistance to daunomycin.

  1999cited by this paper
• Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR.

  1999cited by this paper
• Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

  1999cited by this paper
• Photoaffinity labeling of human P-glycoprotein: effect of modulator interaction and ATP hydrolysis on substrate binding.

  1998cited by this paper
• Radioligand-Binding Assay Employing P-Glycoprotein-Overexpressing Cells: Testing Drug Affinities to the Secretory Intestinal Multidrug Transporter

  1998cited by this paper
• A multidrug resistance transporter from human MCF-7 breast cancer cells.

  1998cited by this paper
• A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance.

  1998cited by this paper
• Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein.

  1998cited by this paper
• Binding of steroid modulators to recombinant cytosolic domain from mouse P-glycoprotein in close proximity to the ATP site.

  1997cited by this paper
• Overexpression and purification of the carboxyl-terminal nucleotide-binding domain from mouse P-glycoprotein. Strategic location of a tryptophan residue.

  1994cited by this paper
• Structural mapping of catalytic site with respect to alpha-subunit and noncatalytic site in yeast mitochondrial F1-ATPase using fluorescence resonance energy transfer.

  1993cited by this paper
• Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

  1992cited by this paper
• ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells.

  1992cited by this paper
• A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

  1976cited by this paper

• Structures of ABCG2 under turnover conditions reveal a key step in the drug transport mechanism

  2021cites this paper
• Analysis of Sequence Divergence in Mammalian ABCGs Predicts a Structural Network of Residues That Underlies Functional Divergence

  2021cites this paper
• Tetrahydroquinoline/4,5‐Dihydroisoxazole Molecular Hybrids as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2)

  2021cites this paper
• ATP‐binding cassette (ABC) transporters in cancer: A review of recent updates

  2021cites this paper
• M3814, a DNA-PK Inhibitor, Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer Cells

  2020cites this paper
• Picky ABCG5/G8 and promiscuous ABCG2 ‐ a tale of fatty diets and drug toxicity

  2020cites this paper
• Novel Targets and Biomarkers in Solid Tumors

  2020cites this paper
• Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance

  2020cites this paper
• Overexpression of ABCG2 confers resistance to pevonedistat, an NAE inhibitor.

  2020cites this paper
• ABCG2 Overexpression Contributes to Pevonedistat Resistance

  2020cites this paper
• Y6, an Epigallocatechin Gallate Derivative, Reverses ABCG2-Mediated Mitoxantrone Resistance

  2019cites this paper
• Integrated Application of Enhanced Replacement Method and Ensemble Learning for the Prediction of BCRP/ABCG2 Substrates

  2017cites this paper
• PharmGKB summary: very important pharmacogene information for ABCG2

  2017cites this paper
• Structure-function relationships in ABCG2: insights from molecular dynamics simulations and molecular docking studies

  2017cites this paper
• The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade.

  2015cites this paper
• Marine Natural Products as Breast Cancer Resistance Protein Inhibitors

  2015cites this paper
• Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance

  2014cites this paper
• Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics

  2014cites this paper
• New insights into the role of breast cancer resistance protein in endocrine and metabolic processes

  2014cites this paper
• Determinants of the activity and substrate recognition of breast cancer resistance protein (ABCG2)

  2014influential citation
• Recombinant Human Melatonin Receptor MT1 Isolated in Mixed Detergents Shows Pharmacology Similar to That in Mammalian Cell Membranes

  2014cites this paper
• Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance

  2014cites this paper
• Quinoline carboxamides as modulators of Breast Cancer Resistance Protein (ABCG2): Investigations on potency, selectivity, mechanism of action, cytotoxicity, stability and drug-like properties

  2014cites this paper
• A Mutation within the Extended X Loop Abolished Substrate-induced ATPase Activity of the Human Liver ATP-binding Cassette (ABC) Transporter MDR3*

  2014cites this paper
• Baicalein decreases side population proportion via inhibition of ABCG2 in multiple myeloma cell line RPMI 8226 in vitro.

  2014cites this paper
• β-Lactam Selectivity of Multidrug Transporters AcrB and AcrD Resides in the Proximal Binding Pocket*

  2014cites this paper
• Effects of the lipid environment, cholesterol and bile acids on the function of the purified and reconstituted human ABCG2 protein.

  2013cites this paper
• Development of Conformation Independent Computational Models for the Early Recognition of Breast Cancer Resistance Protein Substrates

  2013cites this paper
• Methoxy stilbenes as potent, specific, untransported, and noncytotoxic inhibitors of breast cancer resistance protein.

  2012cites this paper
• Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: in vitro optimization and in vivo validation.

  2011cites this paper
• Dimerization of ABCG2 Analysed by Bimolecular Fluorescence Complementation

  2011cites this paper
• Contributions of TM5, ECL3 and TM6 of human BCRP to its oligomerization activities and transport functions

  2011cites this paper
• Recombinant Synthesis of Human ABCG2 Expressed in the Yeast Saccharomyces cerevisiae: an Experimental Methodological Study

  2011cites this paper
• A new ATP‐binding cassette protein is involved in intracellular haem trafficking in Leishmania

  2011cites this paper
• Caracterización de las proteínas LABCG1 y LABCG5 de Leishmania: implicación en el tráfico intracelular de hemo y en la infección de macrófagos

  2011influential citation
• ACTIVE EFFLUX TRANSPORT AND CNS DISTRIBUTION OF THE NOVEL ANTIFOLATE PEMETREXED

  2010cites this paper
• Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport.

  2010cites this paper
• JPET #163493 1 Role of Basic Residues Within or Near the Predicted Transmembrane Helix 2 of the Human Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport

  2010cites this paper
• ABCG2 Transports and Transfers Heme to Albumin through Its Large Extracellular Loop*

  2010cites this paper
• Role of Basic Residues within or near the Predicted Transmembrane Helix 2 of the Human Breast Cancer Resistance Protein in Drug Transport

  2010cites this paper
• Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

  2010influential citation
• The multidrug resistance half-transporter ABCG2 is purified as a tetramer upon selective extraction from membranes.

  2010influential citation
• Mammalian membrane protein expression in baculovirus-infected insect cells.

  2010cites this paper
• Insect cell versus bacterial overexpressed membrane proteins: an example, the human ABCG2 transporter.

  2010cites this paper
• The human breast cancer resistance protein (BCRP/ABCG2) shows conformational changes with mitoxantrone.

  2010cites this paper
• Overexpression of homogeneous and active ABCG2 in insect cells.

  2009cites this paper
• Targeting cancer with 'smart bombs': equipping plant virus nanoparticles for a 'seek and destroy' mission.

  2009cites this paper
• The 315–316 deletion determines the BXP-21 antibody epitope but has no effect on the function of wild type ABCG2 or the Q141K variant

  2009cites this paper
• Arginine 383 is a crucial residue in ABCG2 biogenesis.

  2009cites this paper
• QSAR analysis and molecular modeling of ABCG2-specific inhibitors.

  2009cites this paper
• Purification and structural analyses of ABCG2.

  2009influential citation
• ABCG2: structure, function and role in drug response

  2008cites this paper
• BCRP-Breast Cancer Resistance Protein

  2008cites this paper
• Caractérisation de 2 transporteurs ABC (“ATP-Binding Cassette”) bactériens de fonction inconnue : YheI/YheH de Bacillus subtilis et Rv1747 de Mycobacterium tuberculosis

  2008cites this paper
• ABCG2: structure, function and role in drug response.

  2008cites this paper
• Homology modeling of breast cancer resistance protein (ABCG2).

  2008cites this paper
• Is ATP binding responsible for initiating drug translocation by the multidrug transporter ABCG2?

  2008cites this paper
• The emerging pharmacotherapeutic significance of the breast cancer resistance protein (ABCG2)

  2007cites this paper
• XENOBIOTIC TRANSPORTERS IN LACTATING MAMMARY EPITHELIAL CELLS: PREDICTIONS FOR DRUG ACCUMULATION IN BREAST MILK

  2007cites this paper